Loading...

Zecotek Photonics

TSXV:ZMS
Snowflake Description

Limited growth with worrying balance sheet.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
ZMS
TSXV
CA$11M
Market Cap
  1. Home
  2. CA
  3. Healthcare
Company description

Zecotek Photonics Inc., a photonics technology company, develops various photonics technologies and products for commercial and research applications in medical, bio-science, high-energy physics, pharmaceutical research, material processing, engineering and industrial design, and multi-media markets. The last earnings update was 17 days ago. More info.


Add to Portfolio Compare Print
  • Zecotek Photonics has significant price volatility in the past 3 months.
ZMS Share Price and Events
7 Day Returns
-17.6%
TSXV:ZMS
3.8%
CA Medical Equipment
2.1%
CA Market
1 Year Returns
-75.9%
TSXV:ZMS
-45.3%
CA Medical Equipment
-9.3%
CA Market
ZMS Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Zecotek Photonics (ZMS) -17.6% 0% -50% -75.9% -77.8% -91.3%
CA Medical Equipment 3.8% 34.2% 7.9% -45.3% -56.6% -74.3%
CA Market 2.1% 7.5% -2.4% -9.3% 23.2% 5.2%
1 Year Return vs Industry and Market
  • ZMS underperformed the Medical Equipment industry which returned -45.3% over the past year.
  • ZMS underperformed the Market in Canada which returned -9.3% over the past year.
Price Volatility
ZMS
Industry
5yr Volatility vs Market

ZMS Value

 Is Zecotek Photonics undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.

In this section, we usually try to help investors determine whether Zecotek Photonics is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Zecotek Photonics has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis. You can see them here.

Show me the analysis anyway

INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for Zecotek Photonics. This is due to cash flow or dividend data being unavailable. The share price is CA$0.07.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Zecotek Photonics's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Zecotek Photonics's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
TSXV:ZMS PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-10-31) in CAD CA$-0.04
TSXV:ZMS Share Price ** TSXV (2019-01-18) in CAD CA$0.07
North America Medical Equipment Industry PE Ratio Median Figure of 64 Publicly-Listed Medical Equipment Companies 47.76x
Canada Market PE Ratio Median Figure of 556 Publicly-Listed Companies 14.1x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Zecotek Photonics.

TSXV:ZMS PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= TSXV:ZMS Share Price ÷ EPS (both in CAD)

= 0.07 ÷ -0.04

-1.94x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Zecotek Photonics is loss making, we can't compare its value to the North America Medical Equipment industry average.
  • Zecotek Photonics is loss making, we can't compare the value of its earnings to the Canada market.
Price based on expected Growth
Does Zecotek Photonics's expected growth come at a high price?
Raw Data
TSXV:ZMS PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -1.94x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 1 Analysts
Not available
North America Medical Equipment Industry PEG Ratio Median Figure of 54 Publicly-Listed Medical Equipment Companies 2.72x
Canada Market PEG Ratio Median Figure of 264 Publicly-Listed Companies 0.96x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Zecotek Photonics, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Zecotek Photonics's assets?
Raw Data
TSXV:ZMS PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-10-31) in CAD CA$-0.03
TSXV:ZMS Share Price * TSXV (2019-01-18) in CAD CA$0.07
Canada Medical Equipment Industry PB Ratio Median Figure of 18 Publicly-Listed Medical Equipment Companies 4.29x
Canada Market PB Ratio Median Figure of 2,295 Publicly-Listed Companies 1.46x
TSXV:ZMS PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= TSXV:ZMS Share Price ÷ Book Value per Share (both in CAD)

= 0.07 ÷ -0.03

-2.64x

* Primary Listing of Zecotek Photonics.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Zecotek Photonics has negative assets, we can't compare the value of its assets to the CA Medical Equipment industry average.

Next steps:

  1. Take a look at our analysis of ZMS’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  2. When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through Zecotek Photonics's regulatory filings and announcements.
  3. Show me more potentially undervalued companies in the Medical Equipment industry
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Value checks
We assess Zecotek Photonics's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Medical Equipment industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Medical Equipment industry average (and greater than 0)? (1 check)
  5. Zecotek Photonics has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

ZMS Future Performance

 How is Zecotek Photonics expected to perform in the next 1 to 3 years based on estimates from 1 analyst?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
118.6%
Expected annual growth in revenue.
Earnings growth vs Low Risk Savings
Is Zecotek Photonics expected to grow at an attractive rate?
  • Unable to compare Zecotek Photonics's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare Zecotek Photonics's earnings growth to the Canada market average as no estimate data is available.
  • Zecotek Photonics's revenue growth is expected to exceed the Canada market average.
Annual Growth Rates Comparison
Raw Data
TSXV:ZMS Future Growth Rates Data Sources
Data Point Source Value (per year)
TSXV:ZMS Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 1 Analysts 118.6%
Canada Medical Equipment Industry Earnings Growth Rate Market Cap Weighted Average 8.2%
Canada Medical Equipment Industry Revenue Growth Rate Market Cap Weighted Average 31.2%
Canada Market Earnings Growth Rate Market Cap Weighted Average 14.4%
Canada Market Revenue Growth Rate Market Cap Weighted Average 7.1%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
TSXV:ZMS Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below
All numbers in CAD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
TSXV:ZMS Future Estimates Data
Date (Data in CAD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2020-07-31 11 1
2019-07-31 5 1
TSXV:ZMS Past Financials Data
Date (Data in CAD Millions) Revenue Cash Flow Net Income *
2018-10-31 0 -7 -6
2018-07-31 0 -6 -5
2018-04-30 0 -6 -5
2018-01-31 0 -5 -4
2017-10-31 0 -4 -3
2017-07-31 0 -4 -3
2017-04-30 1 -4 -3
2017-01-31 1 -4 -3
2016-10-31 2 -4 -5
2016-07-31 1 -4 -5
2016-04-30 1 -4 -5
2016-01-31 1 -5 -6

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if Zecotek Photonics is high growth as no earnings estimate data is available.
  • Zecotek Photonics's revenue is expected to grow significantly at over 20% yearly.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
TSXV:ZMS Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below

All data from Zecotek Photonics Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

TSXV:ZMS Future Estimates Data
Date (Data in CAD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2020-07-31
2019-07-31
TSXV:ZMS Past Financials Data
Date (Data in CAD Millions) EPS *
2018-10-31 -0.04
2018-07-31 -0.03
2018-04-30 -0.03
2018-01-31 -0.03
2017-10-31 -0.02
2017-07-31 -0.03
2017-04-30 -0.03
2017-01-31 -0.03
2016-10-31 -0.04
2016-07-31 -0.04
2016-04-30 -0.05
2016-01-31 -0.05

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Zecotek Photonics will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess Zecotek Photonics's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Canada market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Canada market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Zecotek Photonics has a total score of 2/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

ZMS Past Performance

  How has Zecotek Photonics performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Zecotek Photonics's growth in the last year to its industry (Medical Equipment).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Zecotek Photonics does not make a profit even though their year on year earnings growth rate was positive over the past 5 years.
  • Unable to compare Zecotek Photonics's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Zecotek Photonics's 1-year growth to the North America Medical Equipment industry average as it is not currently profitable.
Earnings and Revenue History
Zecotek Photonics's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Zecotek Photonics Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

TSXV:ZMS Past Revenue, Cash Flow and Net Income Data
Date (Data in CAD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-10-31 0.01 -5.74 6.28 0.57
2018-07-31 0.20 -4.95 5.98 0.57
2018-04-30 0.24 -4.59 5.36 0.78
2018-01-31 0.45 -3.57 4.36 0.87
2017-10-31 0.45 -2.73 3.65 1.04
2017-07-31 0.47 -3.42 3.63 1.28
2017-04-30 0.79 -3.46 3.74 1.36
2017-01-31 0.85 -3.27 3.54 1.30
2016-10-31 1.55 -5.25 4.01 1.47
2016-07-31 1.49 -5.24 4.01 1.49
2016-04-30 1.33 -5.26 4.01 1.50
2016-01-31 1.13 -5.65 4.32 1.57
2015-10-31 0.50 -6.02 4.67 1.49
2015-07-31 0.45 -7.17 5.83 1.47
2015-04-30 0.27 -9.75 11.36 1.67
2015-01-31 0.21 -10.48 10.54 1.74
2014-10-31 0.18 -9.83 8.16 1.71
2014-07-31 0.09 -8.45 6.86 1.62
2014-04-30 0.09 -8.97 3.22 1.42
2014-01-31 0.08 -7.92 3.28 1.24
2013-10-31 0.05 -7.18 3.87 0.95
2013-07-31 0.04 -7.07 3.21 0.93
2013-04-30 0.02 -3.68 0.21 0.83
2013-01-31 0.02 -3.89 0.11 0.87
2012-10-31 0.03 -4.63 0.22 1.03
2012-07-31 0.04 -5.16 0.23 1.24
2012-04-30 0.06 -6.78 0.72 1.68
2012-01-31 0.06 -6.77 0.65 1.01

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Zecotek Photonics has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) due to its liabilities exceeding its assets.
  • It is difficult to establish if Zecotek Photonics has efficiently used its assets last year compared to the North America Medical Equipment industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Zecotek Photonics improved its use of capital last year versus 3 years ago (Return on Capital Employed) due to its liabilities exceeding its assets.
X
Past performance checks
We assess Zecotek Photonics's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Medical Equipment industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Zecotek Photonics has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

ZMS Health

 How is Zecotek Photonics's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Zecotek Photonics's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Zecotek Photonics's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
  • Zecotek Photonics has no long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Zecotek Photonics's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Zecotek Photonics has negative shareholder equity (liabilities exceed assets) therefore debt is not covered by short term assets.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Zecotek Photonics Company Filings, last reported 2 months ago.

TSXV:ZMS Past Debt and Equity Data
Date (Data in CAD Millions) Total Equity Total Debt Cash & Short Term Investments
2018-10-31 -0.62 0.00 2.70
2018-07-31 0.47 0.00 2.42
2018-04-30 2.22 0.19 4.83
2018-01-31 -1.87 0.00 3.11
2017-10-31 -5.87 0.01 0.29
2017-07-31 -6.21 0.02 0.86
2017-04-30 -6.68 0.03 0.33
2017-01-31 -6.12 0.05 0.42
2016-10-31 -7.75 0.05 0.02
2016-07-31 -7.44 0.05 0.24
2016-04-30 -7.10 0.00 0.01
2016-01-31 -6.77 0.00 0.29
2015-10-31 -6.78 0.00 0.10
2015-07-31 -5.81 0.00 0.35
2015-04-30 -4.25 0.00 1.38
2015-01-31 -3.09 0.00 3.32
2014-10-31 -3.39 0.00 0.26
2014-07-31 -2.83 0.00 0.62
2014-04-30 -0.34 0.00 2.23
2014-01-31 -1.41 0.00 1.48
2013-10-31 -0.28 0.00 2.50
2013-07-31 -2.66 0.00 0.21
2013-04-30 -2.45 0.04 0.22
2013-01-31 -2.84 0.26 0.08
2012-10-31 -2.43 0.01 0.39
2012-07-31 -3.12 0.66 0.13
2012-04-30 -2.32 0.01 0.08
2012-01-31 -1.38 0.01 0.61
  • Zecotek Photonics has negative shareholder equity (liabilities exceed assets), this is a more serious situation compared with a high debt level.
  • Irrelevant to check if Zecotek Photonics's debt level has increased considering it has negative shareholder equity.
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Zecotek Photonics has less than a year of cash runway based on current free cash flow.
  • Zecotek Photonics has less than a year of cash runway if free cash flow continues to grow at historical rates of 43% each year.
X
Financial health checks
We assess Zecotek Photonics's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Zecotek Photonics has a total score of 1/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

ZMS Dividends

 What is Zecotek Photonics's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Zecotek Photonics dividends.
If you bought CA$2,000 of Zecotek Photonics shares you are expected to receive CA$0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Zecotek Photonics's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Zecotek Photonics's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
TSXV:ZMS Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below
North America Medical Equipment Industry Average Dividend Yield Market Cap Weighted Average of 23 Stocks 1.3%
Canada Market Average Dividend Yield Market Cap Weighted Average of 328 Stocks 3.6%
Canada Minimum Threshold Dividend Yield 10th Percentile 1.2%
Canada Bottom 25% Dividend Yield 25th Percentile 2.2%
Canada Top 25% Dividend Yield 75th Percentile 6.1%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

TSXV:ZMS Future Dividends Estimate Data
Date (Data in CA$) Dividend per Share (annual) Avg. No. Analysts
2020-07-31
2019-07-31

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Zecotek Photonics has not reported any payouts.
  • Unable to verify if Zecotek Photonics's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Zecotek Photonics's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Zecotek Photonics has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Zecotek Photonics's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.2%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Zecotek Photonics afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Zecotek Photonics has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

ZMS Management

 What is the CEO of Zecotek Photonics's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
A. Zerrouk
COMPENSATION CA$632,558
TENURE AS CEO 14 years
CEO Bio

Dr. A. Faouzi Zerrouk is the Founder of Zecotek Photonics Inc and has been its Chairman, President and Chief Executive Officer since December 31, 2004. Dr. Zerrouk Principal Founder of Zecotek Holdings Ltd., where he served as President and Head of Research from 2002 to 2004 and Chief Executive Officer from 2004 to 2005. At the Institute of General Physics, Moscow, Dr. Zerrouk worked with the group of the Nobel Laureate Academician Prokhorov where he co-developed RGB and UV micro-chipset lasers with large market applications. He also established commercially driven private R&D labs based in Russia in the fields of crystals & lasers, holographic, 3D displays, new materials, nanostructures, optical networks and communication subsystems. In 1989, he established the first foreign partnered, private, business oriented photonics research Lab in the Ex-Soviet Union (Novosibirsk, Siberia). Working closely with the Ministry of Science and Technology Dr. Zerrouk served as technology transfer advisor during the transition period to the Russian federation, providing Research and Development strategies for the new economy with prominent members of the Russian Academy of Science. He serves as the Chairman of Scientific Advisory Board at Zecotek Photonics Inc. Dr. Zerrouk served as the Executive Chairman of Zecotek Holdings Ltd. from 2002 to 2004. He is the co-owner at Zecotek Holdings Singapore Pte. Ltd. He has been a Director of Zecotek Photonics Inc since December 31, 2004. From 1987 to 1993, Dr. Zerrouk held research and faculty positions at various centers including the Clarendon Laboratory, University of Oxford, England, (Atomic & Laser physics), Siberian Academy of Sciences (TOKAMAK and Laser fusion research), the Institute of Thermal Processes, Moscow (high-power gas dynamic lasers). Dr. Zerrouk received his PhD in Theoretical Physics in 1987 from the University of Sussex, England.

CEO Compensation
  • A.'s compensation has been consistent with company performance over the past year.
  • A.'s remuneration is higher than average for companies of similar size in Canada.
Management Team Tenure

Average tenure of the Zecotek Photonics management team in years:

11.8
Average Tenure
  • The average tenure for the Zecotek Photonics management team is over 5 years, this suggests they are a seasoned and experienced team.
Management Team

A. Zerrouk

TITLE
Founder
COMPENSATION
CA$633K
TENURE
14 yrs

Azman Ariffin

TITLE
Chief Operations Officer
COMPENSATION
CA$54K

Serge Khorev

TITLE
Senior Vice President of Technology
TENURE
7.6 yrs

Zair Sadygov

TITLE
Chief Scientist of Medical Imaging Division
TENURE
11.8 yrs

Shirley Kancs

TITLE
Assistant Secretary
COMPENSATION
CA$22K
AGE
65
Board of Directors Tenure

Average tenure of the Zecotek Photonics board of directors in years:

11.2
Average Tenure
  • The average tenure for the Zecotek Photonics board of directors is over 10 years, this suggests they are a seasoned and experienced board.
Board of Directors

A. Zerrouk

TITLE
Founder
COMPENSATION
CA$633K
TENURE
14.1 yrs

Erich Sager

TITLE
Independent Director
COMPENSATION
CA$24K
AGE
60
TENURE
14 yrs

Thomas Lewellen

TITLE
Member of Scientific Advisory Board

Tiong-Ann Teoh

TITLE
Member of Scientific Advisory Board
TENURE
11.2 yrs

Zelong He

TITLE
Director
TENURE
0.2 yrs

Sergy Tsakunov

TITLE
Director
TENURE
0.2 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (CA$) Value (CA$)
18. Apr 18 Buy Michael Minder Individual 12. Apr 18 12. Apr 18 178,229 CA$0.32 CA$57,033
18. Apr 18 Buy Erich Sager Individual 12. Apr 18 12. Apr 18 235,102 CA$0.32 CA$75,233
14. Apr 18 Buy Robert Toyoda Individual 12. Apr 18 12. Apr 18 262,266 CA$0.32 CA$83,925
X
Management checks
We assess Zecotek Photonics's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Zecotek Photonics has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

ZMS News

External News
Loading...
Simply Wall St News

Is Zecotek Photonics Inc's (CVE:ZMS) CEO Pay Justified?

First, this article will compare CEO compensation with compensation at similar sized companies. … Zerrouk's Compensation Compare With Similar Sized Companies. … Zerrouk receives more in total compensation than the median of a group of companies in the same market, and of similar size to Zecotek Photonics Inc.

Simply Wall St -

Want To Invest In Zecotek Photonics Inc (CVE:ZMS)? Here's How It Performed Lately

Examining Zecotek Photonics Inc's (TSXV:ZMS) past track record of performance is an insightful exercise for investors. … Check out our latest analysis for Zecotek Photonics Did ZMS perform worse than its track record and industry? … TSXV:ZMS Income Statement Jun 3rd 18 We can further evaluate Zecotek Photonics's loss by looking at what the industry has been experiencing over the past few years.

Simply Wall St -

How Should You Think About Zecotek Photonics Inc's (CVE:ZMS) Risks?

A widely-used metric to measure a stock's market risk is beta, and the broad market index represents a beta value of one. … ZMS’s beta indicates it is a stock that investors may find valuable if they want to reduce the overall market risk exposure of their stock portfolio. … As a result, the company may be less volatile relative to broad market movements, compared to a company of similar size but higher proportion of fixed assets.

Simply Wall St -

What You Must Know About Zecotek Photonics Inc's (CVE:ZMS) Major Investors

In this article, I'm going to take a look at Zecotek Photonics Inc’s (TSXV:ZMS) latest ownership structure, a non-fundamental factor which is important, but remains a less discussed subject among investors. … View our latest analysis for Zecotek Photonics TSXV:ZMS Ownership_summary Apr 11th 18 Insider Ownership I find insiders are another important group of stakeholders, who are directly involved in making key decisions related to the use of capital. … ZMS insiders are also influential stakeholders with 7.75% ownership in the company.

Simply Wall St -

Does Zecotek Photonics Inc (CVE:ZMS) Have Enough Money Left To Grow?

Cash is crucial to run a business, and if a company burns through its reserves fast, it will need to come back to market for additional capital raising. … The measure of how fast Zecotek Photonics goes through its cash reserves over time is called the cash burn rate. … But, if Zecotek Photonics continues to ramp up its opex at this rate, given how much money it currently has in the bank, it will actually need to come to market again within the next year.

Simply Wall St -

Is Zecotek Photonics Inc's (CVE:ZMS) CEO Incentives Align With Yours?

Earnings is a powerful indication of ZMS's ability to invest shareholders' funds and generate returns. … Therefore I will use earnings as a proxy of Zerrouk's performance in the past year? … Normally I'd use market cap and profit as factors determining performance, however, ZMS's negative earnings reduces the effectiveness of this method.

Simply Wall St -

Does Zecotek Photonics Inc's (CVE:ZMS) Earnings Growth Make It An Outperformer?

Below, I will assess Zecotek Photonics Inc's (TSXV:ZMS) track record on a high level, to give you some insight into how the company has been performing against its historical trend and its industry peers. … See our latest analysis for Zecotek Photonics Did ZMS beat its long-term earnings growth trend and its industry? … For Zecotek Photonics, its most recent earnings (trailing twelve month) is -CA$2.73M, which, in comparison to last year’s figure, has become less negative.

Simply Wall St -

What You Must Know About Zecotek Photonics Inc's (CVE:ZMS) Risks

A popular measure of market risk for a stock is its beta, and the market as a whole represents a beta value of one. … Based on this beta value, ZMS appears to be a stock that an investor with a high-beta portfolio would look for to reduce risk exposure to the market. … ZMS, with its market capitalisation of CA$42.91M, is a small-cap stock, which generally have higher beta than similar companies of larger size.

Simply Wall St -

Should You Be Concerned About Zecotek Photonics Inc's (CVE:ZMS) Investors?

Today, I will be analyzing Zecotek Photonics Inc’s (TSXV:ZMS) recent ownership structure, an important but not-so-popular subject among individual investors. … View our latest analysis for Zecotek Photonics TSXV:ZMS Ownership_summary Dec 13th 17 Insider Ownership I find insiders are another important group of stakeholders, who are directly involved in making key decisions related to the use of capital. … This level of ownership gives retail investors the power to sway key policy decisions such as board composition, executive compensation, and potential acquisitions.

Simply Wall St -

Does Zecotek Photonics Inc's (TSXV:ZMS) Past Performance Indicate A Stronger Future?

After looking at Zecotek Photonics Inc's (TSXV:ZMS) latest earnings update (31 July 2017), I found it helpful to revisit the company's performance in the past couple of years and compare this against the latest numbers. … For the most up-to-date info, I use the ‘latest twelve-month’ data, which either annualizes the most recent 6-month earnings update, or in some cases, the most recent annual report is already the latest available financial data. … For Zecotek Photonics, the most recent twelve-month earnings -CA$3.4M, which, relative to last year’s level, has become less negative.

Simply Wall St -

ZMS Company Info

Map
Description

Zecotek Photonics Inc., a photonics technology company, develops various photonics technologies and products for commercial and research applications in medical, bio-science, high-energy physics, pharmaceutical research, material processing, engineering and industrial design, and multi-media markets. The company operates through three divisions: Zecotek Imaging China, Zecotek Optronics Systems, and Zecotek Autotronics. Its imaging systems include lutetium fine silicate scintillation crystals; solid-state micro-pixel avalanche photo diode photo detectors and transistors; and integrated detector modules. The company also develops glasses-free 3D displays; and 3D auto-stereoscopic displays, and 3D printers and related technologies for applications in healthcare, scientific, and industrial markets. Zecotek Photonics Inc. in Asia and North America. Its strategic partners primarily include Nucare Ltd., University of Washington, and University of California. The company was formerly known as Zecotek Medical Systems Inc. and changed its name to Zecotek Photonics Inc. in November 2007. Zecotek Photonics Inc. was incorporated in 1983 and is headquartered in Richmond, Canada.

Details
Name: Zecotek Photonics Inc.
ZMS
Exchange: TSXV
Founded: 1983
CA$11,482,110
164,030,148
Website: http://www.zecotek.com
Address: Zecotek Photonics Inc.
21331 Gordon Way,
Unit 1120,
Richmond,
British Columbia, V6W 1J9,
Canada
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
TSXV ZMS Common Shares TSX Venture Exchange CA CAD 13. Sep 1988
OTCPK ZMSP.F Common Shares Pink Sheets LLC US USD 13. Sep 1988
DB W1I Common Shares Deutsche Boerse AG DE EUR 13. Sep 1988
Number of employees
Current staff
Staff numbers
0
Zecotek Photonics employees.
Industry
Health Care Equipment
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/01/20 00:04
End of day share price update: 2019/01/18 00:00
Last estimates confirmation: 2018/11/29
Last earnings filing: 2019/01/03
Last earnings reported: 2018/10/31
Last annual earnings reported: 2018/07/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.